ANMOL TOLANI: Open Payments
NPI 1326482688 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,850 in 90 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,837 · 2025 $3,850
Food & beverage: $2,139Travel & lodging: $1,711
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $1,711 |
| E.R. Squibb & Sons, L.L.C. | 15 | $532 |
| Janssen Pharmaceuticals, Inc | 25 | $492 |
| ABBVIE INC. | 13 | $296 |
| Otsuka America Pharmaceutical, Inc. | 11 | $290 |
| Braeburn Inc. | 7 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Alkermes, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: Deep TMS System, COBENFY, SPRAVATO, VRAYLAR, REXULTI, BRIXADI, INVEGA SUSTENNA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
